hyperCORE International Strengthens Executive Team with New Vice President and Treasurer Appointments

hyperCORE International, a leading collaborative network of clinical trial sites across North America, has announced updates to its executive leadership team with the appointment of Jeffrey Smyth as Vice President and Olivia McIver as Treasurer. Smyth, who serves as President and Executive Director of partner site network TrueBlue Clinical Research, and McIver, Director of Clinical Operations at partner site network Applied Research Center, bring complementary expertise to strengthen the organization's governance and ensure continued alignment with hyperCORE's mission of driving efficiency and excellence across its collective partner site networks.

These strategic appointments are designed to support hyperCORE's growth trajectory and enhance financial stewardship while maintaining the organization's strategic mobility across the clinical research industry. The new leadership structure will play a key role in overseeing the network's financial management and supporting long-term sustainability initiatives. hyperCORE's partner site networks include AGA Clinical Trials; Alcanza Clinical Research; Apex Trials; Applied Research Center; Atlas Clinical Research; CaRe Clinics; Epic Medical Research; FOMAT Medical Research; TrueBlue Clinical Research; and QCR Network, all operating within harmonized operational frameworks that streamline study delivery at scale.

Nicholas Focil, President of hyperCORE, emphasized the importance of these appointments for the organization's continued development. "hyperCORE's strength lies in its ability to unify best-in-class research sites through shared operational excellence," Focil stated. "As we continue to grow, having a dedicated and strategic Vice President and integrated board Treasurer is essential to guide our leadership framework and maintain our strategic mobility across our industry." The executive team expansion comes as hyperCORE continues to strengthen its position in the clinical research landscape.

Alongside these new appointments, Nicholas Focil, CEO of FOMAT Medical Research, will continue serving as President, and Mark Scullion, CEO of Atlas Clinical Research, will maintain his role as Secretary, providing consistent leadership to guide hyperCORE's next phase of growth. hyperCORE International represents a partner site network of leading clinical research site organizations, boasting over 80 active trial sites across five countries and two continents. The network's partners have collectively completed more than 7,500 studies involving over 150,000 randomized participants, demonstrating the scale and impact of their collaborative approach to clinical research.

Each partner member operates independently while integrating harmonized operational frameworks to optimize efficiency, standardization, and excellence across the network. hyperCORE remains committed to advancing clinical research through safe, ethical, and timely studies, efficient enrollment processes, and superior retention rates. The organization's members have earned top-tier awards for performance, quality, and innovation, further validating the effectiveness of their collaborative model in the competitive clinical research landscape.